Who
Janice Suzann Drew
Chief of Dev. Operations
Company insider
Files Form 4 as: Chief of Dev. Operations, Evommune.
In numbers
- Trades disclosed
- 16
- Buys
- 0
- Sells
- 1
- Bought
- $0
- Sold
- $905K
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 5 Nov 2025
- Last trade
- 22 Jun 2026
- Last filed
- 24 Jun 2026
Companies traded
Activity over time
1 Jun – 1 Oct
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 22 Jun 2026filed 24 Jun 2026 | EVMN EvommuneBiotechnology | SEC FORM 4 Code M | $15K3,839 at $3.84 | filing |
| 22 Jun 2026filed 24 Jun 2026 | EVMN EvommuneBiotechnology | SEC FORM 4 Code M | $48K16,161 at $2.99 | filing |
| 22 Jun 2026filed 24 Jun 2026 | EVMN EvommuneBiotechnology | SEC FORM 4 Sold | $453K20,000 at $22.63 | filing |
| 22 Jun 2026filed 24 Jun 2026 | EVMN Evommuneoption or derivative · Biotechnology | SEC FORM 4 Code M | —3,839 at $0.00 | filing |
| 22 Jun 2026filed 24 Jun 2026 | EVMN Evommuneoption or derivative · Biotechnology | SEC FORM 4 Code M | —16,161 at $0.00 | filing |
| 22 Jun 2026filed 24 Jun 2026 | EVMN Evommuneoption or derivative · Biotechnology | SEC FORM 4 Code M | —3,839 at $0.00 | filing |
| 22 Jun 2026filed 24 Jun 2026 | EVMN Evommuneoption or derivative · Biotechnology | SEC FORM 4 Code M | —16,161 at $0.00 | filing |
| 22 Jun 2026filed 24 Jun 2026 | EVMN EvommuneBiotechnology | SEC FORM 4 Code M | $15K3,839 at $3.84 | filing |
| 22 Jun 2026filed 24 Jun 2026 | EVMN EvommuneBiotechnology | SEC FORM 4 Code M | $48K16,161 at $2.99 | filing |
| 22 Jun 2026filed 24 Jun 2026 | EVMN EvommuneBiotechnology | SEC FORM 4 Sold | $453K20,000 at $22.63 | filing |
| 16 Apr 2026filed 17 Apr 2026 | EVMN Evommuneoption or derivative · Biotechnology | SEC FORM 4 Code A | —73,892 at $0.00 | filing |
| 16 Apr 2026filed 17 Apr 2026 | EVMN Evommuneoption or derivative · Biotechnology | SEC FORM 4 Code A | —73,892 at $0.00 | filing |
| 9 Dec 2025filed 11 Dec 2025 | EVMN EvommuneBiotechnology | SEC FORM 4 Code F | $91K5,074 at $17.84 | filing |
| 7 Nov 2025filed 12 Nov 2025 | EVMN Evommuneoption or derivative · Biotechnology | SEC FORM 4 Code C | —12,500 | filing |
| 7 Nov 2025filed 12 Nov 2025 | EVMN EvommuneBiotechnology | SEC FORM 4 Code C | —1,587 | filing |
| 5 Nov 2025filed 7 Nov 2025 | EVMN Evommuneoption or derivative · Biotechnology | SEC FORM 4 Code A | —231,274 at $0.00 | filing |
News
Evommune (NYSE:EVMN) Stock Bumped Up to "Hold" by UBS GroupEVMN · tickerreport.com · 14 Oct 2026Evommune (NYSE:EVMN) Upgraded at UBS GroupEVMN · dailypolitical.com · 14 Oct 2026
0 headlines in the last 90 days name Janice Suzann Drew; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.